Literature DB >> 9734677

Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis.

N P Hurst1, D A Ruta, P Kind.   

Abstract

OBJECTIVE: To compare the performance of the MOS SF12 health survey (SF12) with the SF36 in a sample of 233 patients with rheumatoid arthritis (RA) stratified by functional class.
METHODS: The SF12 and SF36 physical and mental component summary scales (PCS and MCS) were compared for test retest reliability [intra-class correlation coefficient (RC) and repeatability], construct validity and responsiveness [standardized response mean (SRM)] to self-reported change in health.
RESULTS: Overall, despite its brevity, the SF12 is comparable to the SF36 with only some loss of performance. The SF12-PCS is slightly less reliable (RC = 0.75) and responsive to improvements in health (SRM = 0.52) than the SF36-PCS (RC = 0.81; SRM = 0.61). The SF12-PCS correlates strongly with the SF36-PCS (R = 0.94), SF36 physical function subscale (R = 0.77) and modified Stanford Health Assessment Questionnaire (MHAQ) (R = 0.71), but only weakly with the SF36 mental health subscale (R = 0.22). SF12-PCS discriminated well between Steinbrocker functional classes; patients in functional classes 1-4, respectively, have SF12-PCS scores 1sigma, 2sigma, 2.4sigma and 2.7sigma below the population norm (ANOVA, F = 35.8, P < 0.000). The SF12-MCS is relatively unresponsive to reported improvement in RA (SRM = 0.31), but is reliable (RC = 0.71) and correlates well with the SF36-MCS (R = 0.71). SF12-MCS correlates more closely than the SF36-MCS with the SF36 mental health subscale (R = 0.86) and Hospital Anxiety and Depression (HAD) scale (R = 0.76). In ANOVA models, only the HAD (R2 = 57%) score contributes significantly to variance in SF12-MCS (F = 254.8; P < 0.000), but both the HAD (R2 = 24%) and MHAQ (R2 = 10%) scores contribute to variance in the SF36-MCS (F = 50.9; P < 0.000). Thus, the SF12-MCS has better construct validity for mental health than SF36-MCS in RA subjects. Missing responses to items were high amongst patients in functional class 4 (34%).
CONCLUSION: The SF12 is a reliable, valid and responsive measure of health status in the majority of RA patients, and meets standards required for comparing groups of patients. Its application in the most severely disabled subjects is uncertain.

Entities:  

Mesh:

Year:  1998        PMID: 9734677     DOI: 10.1093/rheumatology/37.8.862

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  66 in total

1.  Do SF-36 summary component scores accurately summarize subscale scores?

Authors:  C Taft; J Karlsson; M Sullivan
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  New Australian population scoring coefficients for the old version of the SF-36 and SF-12 health status questionnaires.

Authors:  Graeme Tucker; Robert Adams; David Wilson
Journal:  Qual Life Res       Date:  2010-05-04       Impact factor: 4.147

3.  Effects of complementary therapy on health in a national U.S. sample of older adults.

Authors:  Ha T Nguyen; Joseph G Grzywacz; Wei Lang; Michael Walkup; Thomas A Arcury
Journal:  J Altern Complement Med       Date:  2010-07       Impact factor: 2.579

4.  Functional Comorbidity Index in chronic rhinosinusitis.

Authors:  Corinna G Levine; Greg E Davis; Edward M Weaver
Journal:  Int Forum Allergy Rhinol       Date:  2015-10-13       Impact factor: 3.858

5.  Comparison of the short form-12 (SF-12) health status questionnaire with the SF-36 in patients with knee osteoarthritis who have replacement surgery.

Authors:  Kate E Webster; Julian A Feller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-01-28       Impact factor: 4.342

6.  Health-related quality of life and comorbidity among older women veterans in the United States.

Authors:  Claudia Der-Martirosian; Kristina M Cordasco; Donna L Washington
Journal:  Qual Life Res       Date:  2013-05-08       Impact factor: 4.147

7.  Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease.

Authors:  J Müller-Nordhorn; S Roll; S N Willich
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

8.  A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients.

Authors:  Eduardo Lacson; Jianglin Xu; Shu-Fang Lin; Sandie Guerra Dean; J Michael Lazarus; Raymond M Hakim
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

9.  Parenting enhancement, interpersonal psychotherapy to reduce depression in low-income mothers of infants and toddlers: a randomized trial.

Authors:  Linda S Beeber; Todd A Schwartz; Diane Holditch-Davis; Regina Canuso; Virginia Lewis; Helen Wilde Hall
Journal:  Nurs Res       Date:  2013 Mar-Apr       Impact factor: 2.381

10.  Patients with active rheumatoid arthritis but only few tender and swollen joints: a subgroup with impaired short term outcome.

Authors:  C Fiehn; S Kessler; W Drexler; H M Lorenz
Journal:  Rheumatol Int       Date:  2008-11-08       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.